NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
CompletedPhase 3
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions: COVID-19
Interventions: AZD7442, Placebo, Remdesivir
Countries: United States, Denmark, Greece, Poland, Singapore, Spain, Switzerland, Uganda
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either a AZD7442 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H4.
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: • Refer to the master protocol (NCT04501978) Exclusion Criteria: * Refer to the master protocol (NCT04501978) * Additional Exclusion Criteria: * Pregnant women * Nursing mothers * Women of child-bearing potential who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with men or practice appropriate contraception through the entire 18 months of the study * Men who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with women of child-bearing potential or to use barrier contraception through the entire 18 months of the study. * In addition, prior to the initial futility assessment which is performed when approximately 150 participants have been enrolled on AZD7442 and 150 on placebo, patients on high-flow oxygen or non-invasive ventilation (category 5 of the pulmonary ordinal outcome) will be excluded. These patients may be eligible for the trial if the initial futility assessment is passed by this agent.
Locations (124)
- Tucson, Arizona, United States
- Tucson, Arizona, United States
- Chula Vista, California, United States
- Fresno, California, United States
- La Mesa, California, United States
- Loma Linda, California, United States
- Long Beach, California, United States
- Los Angeles, California, United States
- Los Angeles, California, United States
- Los Angeles, California, United States
- Mather, California, United States
- Newport Beach, California, United States
- San Diego, California, United States
- San Francisco, California, United States
- San Francisco, California, United States
- San Francisco, California, United States
- Stanford, California, United States
- Torrance, California, United States
- Aurora, Colorado, United States
- Denver, Colorado, United States
- Denver, Colorado, United States
- West Haven, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Washington D.C., District of Columbia, United States
- Bay Pines, Florida, United States
- Clearwater, Florida, United States
- Gainesville, Florida, United States
- Hollywood, Florida, United States
- Miami, Florida, United States
- Tampa, Florida, United States
- + 94 more on CT.gov